Research

Vanderbilt University expands its health care innovation role by joining the ARPA-H Customer Experience Hub as a spoke, aiming to advance patient-centric health care solutions. This is the second spoke designation with ARPA-H, underscoring Vanderbilt’s commitment to transformative health care research and accessibility for all Americans. Read More

The inaugural Middle Tennessee Research Administration and Innovation Network (M-TRAIN) workshop, held at Vanderbilt University and funded by a $100,000 NSF grant, brings Middle Tennessee’s universities together to enhance research administration and foster regional collaboration. Read More

The Vanderbilt Center for Addiction Research, led by Erin Calipari, advances research to understand how addiction and substance use disorder develops in the brain. VCAR’s goals are to develop new pharmaceutical strategies and to destigmatize addiction as a personal failing. Read More

As a Marshall Scholar, considered among the most accomplished undergraduates and recent graduates in the U.S., Neikirk will pursue advanced degrees in social determinants of health and biomedical imaging. Read More

Daniel Balasubramanian, a senior research scientist at Vanderbilt’s Institute for Software Integrated Systems, will lead a four-year $6.89 million grant from the Defense Advanced Research Projects Agency (DARPA) to create realistic network environments used to train cyber agents to counter advanced and persistent cyber threats. Estimates have placed the cost of global cybercrime as high... Read More

Daniel Balasubramanian, a senior research scientist at Vanderbilt’s Institute for Software Integrated Systems, will lead a four-year $6.89 million grant from the Defense Advanced Research Projects Agency (DARPA) to create realistic network environments used to train cyber agents to counter advanced and persistent cyber threats. Estimates have placed the cost of global cybercrime as high... Read More

Daniel M. Fleetwood, Olin H. Landreth Professor of Engineering, has been named a National Academy of Inventors Fellow, the highest professional distinction awarded solely to academic inventors. Fleetwood, who is a professor of electrical engineering as well as physics, is best known for his research into radiation effects on microelectronic devices and materials, low-frequency noise,... Read More

Daniel M. Fleetwood, Olin H. Landreth Professor of Engineering, has been named a National Academy of Inventors Fellow, the highest professional distinction awarded solely to academic inventors. Fleetwood, who is a professor of electrical engineering as well as physics, is best known for his research into radiation effects on microelectronic devices and materials, low-frequency noise,... Read More

The Graduate School will host a special exhibition of student research in February, with the winning presentations included in a time capsule commemorating Vanderbilt’s yearlong Sesquicentennial celebration. Ten graduate students will be selected to present their research in the form of five-minute lightning talks at the event. Submit your research by January 22. Read More

Vanderbilt University Medical Center researchers have discovered why most colorectal tumors escape detection and destruction by the body’s immune system. Read More

Vanderbilt researchers have discovered that beneficial bacteria in the small intestines produce a compound that protects against obesity. Read More

Pasteurization of breast milk affects the concentration of osteopontin, a bioactive protein with roles in intestinal, immunological and brain development — suggesting that osteopontin supplementation should be considered when donor milk is provided to preterm infants. Read More

In just over two years, a Vanderbilt-Neumora collaboration has led to the Phase 1 clinical trial of a treatment for schizophrenia spectrum disorders, which affect 3.7 million adults in the United States. This is the third chemical compound discovered at the Warren Center for Neuroscience Drug Discovery to reach Phase 1 clinical trials.     Read More

A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. Read More

Monica Joanna Elnekaveh was doing everything she could to learn what was causing her 18-month-old daughter’s developmental issues. Her relentless quest to find answers eventually led her to Vanderbilt investigative neurologist Jing-Qiong (Katty) Kang, MD, PhD. Read More

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Read More

Vanderbilt University has been selected as an inaugural spoke for the ARPA-H Investor Catalyst Hub, a crucial component of the ARPANET-H initiative aimed at advancing accessible biomedical innovations. This partnership positions Vanderbilt to access potential funding and networking opportunities and provide input into ARPA-H’s health care research focus areas, aligning with their mission to accelerate equitable health care solutions nationwide. Read More

Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients. Read More

Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. Read More

Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. Read More